Detalles de la búsqueda
1.
A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation.
Am J Transplant
; 20(1): 172-180, 2020 01.
Artículo
Inglés
| MEDLINE | ID: mdl-31397943
2.
Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study.
Am J Transplant
; 20(1): 159-171, 2020 01.
Artículo
Inglés
| MEDLINE | ID: mdl-31509331
3.
Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial.
Vaccine
; 42(10): 2560-2571, 2024 Apr 11.
Artículo
Inglés
| MEDLINE | ID: mdl-38360475
4.
Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study.
Transplantation
; 2024 Apr 01.
Artículo
Inglés
| MEDLINE | ID: mdl-38564451
5.
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years.
Vaccine
; 40(31): 4190-4198, 2022 07 29.
Artículo
Inglés
| MEDLINE | ID: mdl-35690500
6.
Corrigendum to "Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years" [Vaccine 40 (2002) 4190-4198].
Vaccine
; 2024 Jun 18.
Artículo
Inglés
| MEDLINE | ID: mdl-38897894
7.
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients.
Clin Pharmacol Drug Dev
; 5(5): 408-25, 2016 Sep.
Artículo
Inglés
| MEDLINE | ID: mdl-27410490
Resultados
1 -
7
de 7
1
Próxima >
>>